» Articles » PMID: 39325839

DNA Methylation Profiling Identifies TBKBP1 As Potent Amplifier of Cytotoxic Activity in CMV-specific Human CD8+ T Cells

Abstract

Epigenetic mechanisms stabilize gene expression patterns during CD8+ T cell differentiation. Although adoptive transfer of virus-specific T cells is clinically applied to reduce the risk of virus infection or reactivation in immunocompromised individuals, the DNA methylation pattern of virus-specific CD8+ T cells is largely unknown. Hence, we here performed whole-genome bisulfite sequencing of cytomegalovirus-specific human CD8+ T cells and found that they display a unique DNA methylation pattern consisting of 79 differentially methylated regions (DMRs) when compared to memory CD8+ T cells. Among the top demethylated DMRs in cytomegalovirus-specific CD8+ T cells was TBKBP1, coding for TBK-binding protein 1 that can interact with TANK-binding kinase 1 (TBK1) and mediate pro-inflammatory responses in innate immune cells downstream of intracellular virus sensing. Since TBKBP1 has not yet been reported in T cells, we aimed to unravel its role in virus-specific CD8+ T cells. TBKBP1 demethylation in terminal effector CD8+ T cells correlated with higher TBKBP1 expression at both mRNA and protein level, independent of alternative splicing of TBKBP1 transcripts. Notably, the distinct DNA methylation patterns in CD8+ T cell subsets was stable upon long-term in vitro culture. TBKBP1 overexpression resulted in enhanced TBK1 phosphorylation upon stimulation of CD8+ T cells and significantly improved their virus neutralization capacity. Collectively, our data demonstrate that TBKBP1 modulates virus-specific CD8+ T cell responses and could be exploited as therapeutic target to improve adoptive T cell therapies.

References
1.
Zhu L, Li Y, Xie X, Zhou X, Gu M, Jie Z . TBKBP1 and TBK1 form a growth factor signalling axis mediating immunosuppression and tumourigenesis. Nat Cell Biol. 2019; 21(12):1604-1614. PMC: 6901116. DOI: 10.1038/s41556-019-0429-8. View

2.
Link C, Eugster A, Heidenreich F, Rucker-Braun E, Schmiedgen M, Oelschlagel U . Abundant cytomegalovirus (CMV) reactive clonotypes in the CD8(+) T cell receptor alpha repertoire following allogeneic transplantation. Clin Exp Immunol. 2016; 184(3):389-402. PMC: 4872374. DOI: 10.1111/cei.12770. View

3.
Neuenhahn M, Albrecht J, Odendahl M, Schlott F, Dossinger G, Schiemann M . Transfer of minimally manipulated CMV-specific T cells from stem cell or third-party donors to treat CMV infection after allo-HSCT. Leukemia. 2017; 31(10):2161-2171. DOI: 10.1038/leu.2017.16. View

4.
Rodriguez R, Suarez-Alvarez B, Lavin J, Mosen-Ansorena D, Raneros A, Marquez-Kisinousky L . Epigenetic Networks Regulate the Transcriptional Program in Memory and Terminally Differentiated CD8+ T Cells. J Immunol. 2016; 198(2):937-949. DOI: 10.4049/jimmunol.1601102. View

5.
van de Berg P, Yong S, Remmerswaal E, van Lier R, Ten Berge I . Cytomegalovirus-induced effector T cells cause endothelial cell damage. Clin Vaccine Immunol. 2012; 19(5):772-9. PMC: 3346330. DOI: 10.1128/CVI.00011-12. View